Featured Research

from universities, journals, and other organizations

H Pylori Screening May Reduce Gastric Cancer Risk

Date:
February 16, 1999
Source:
University Of Michigan
Summary:
Researchers at the University of Michigan have completed a study that provides compelling clinical and economic evidence for population-based Helicobactor pylori (H pylori) screening to reduce the risk of gastric cancer.

ANN ARBOR---Researchers at the University of Michigan have completed a study that provides compelling clinical and economic evidence for population-based Helicobactor pylori (H pylori) screening to reduce the risk of gastric cancer.

Related Articles


Investigators, employing a comprehensive computer analysis, found that H pylori screening could potentially provide important health benefits at a reasonable cost even if elimination of H pylori reduced the increased risk of gastric cancer by only 15 percent in infected individuals.

The study is published in Archives of Internal Medicine.

H pylori's role in most peptic ulcer disease cases has been well documented. People infected with H pylori are also at an increased risk for gastric cancer, prompting the World Health Organization to classify H pylori as a group 1 carcinogen in humans. However, to date, no clinical trial has demonstrated whether the elimination of H pylori infection actually decreases an infected person's already-increased risk for this relatively rare, but frequently lethal, cancer.

"A clinical trial providing definitive evidence that elimination of H pylori infection reduces gastric cancer risk will not be completed for several years," says A. Mark Fendrick, M.D., associate professor of internal medicine in the U-M Health System. "In the interim, we constructed a computer simulation to estimate the potential health and economic consequences of H pylori screening over a range of cancer risk-reduction.

"The ease and low cost of H pylori diagnosis and treatment should make screening attractive to both patients and health care providers. Interestingly, if elimination of H pylori infection reduces cancer risk significantly, this cancer prevention program has the potential to be more cost-effective than mammography and PSA testing."

This is largely due to two factors. First, gastric cancer strikes earlier in life than other common cancers. Therefore, each gastric cancer case prevented led to a significant number of life-years saved. Second, a person only has to be screened for H pylori once in their lifetime since H pylori infection is usually acquired in childhood and re-infection is extremely rare in adults.

The computer model determined that one-time H pylori screening was cost-effective when H pylori eradication reduced the risk of gastric cancer in infected individuals by as little as 15 percent. The analytical model also estimated that H pylori treatment guided by a simple blood test provided a relatively low cost per life-year saved. If elimination of H pylori lowered the risk of gastric cancer to a level similar to individuals who were never infected, just over $6,000 would need to be spent on screening to save an additional year of life---a dollar amount far lower than many commonly accepted medical interventions.

"We set out to estimate the level of cancer risk-reduction necessary to make it worthwhile to recommend H pylori screening to individuals at low risk of gastric cancer on both clinical and economical grounds," Fendrick says. "Since many Americans have a great fear of cancer, we believed they would undergo a simple blood test and take medications for two weeks to reduce the risk of a rare but highly fatal cancer, even if the definitive evidence was not in."

Fendrick says a parallel could be drawn to prostate-specific antigen testing (PSA) to detect prostate cancer. "Even though there remains uncertainty whether detecting early prostate cancers saves lives, Americans have adopted this strategy with unbridled enthusiasm. This decision is based not entirely on the scientific evidence. I would venture to say that the adoption of this or any unproven cancer screening program is driven by our cancer phobia."

H Pylori is usually treated with a two-week regimen consisting of a combination of two antibiotics and a medication that decreases acid product in the stomach. This treatment plan is successful more than 90 percent of the time in permanently eliminating H pylori infection.

"Population based screening of asymptomatic individuals has the potential to produce real important health benefits in terms of reducing gastric cancer," Fendrick says, "because each gastric cancer case prevented led to a significant number of life-years saved."

The study was conducted by researchers in the Consortium for Health Outcomes, Innovation and Cost-Effectiveness Studies (CHOICES)---a research unit funded jointly by the Departments of Medicine and Surgery devoted to the Multidisciplinary study of the quality and economic impact of health care services.


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "H Pylori Screening May Reduce Gastric Cancer Risk." ScienceDaily. ScienceDaily, 16 February 1999. <www.sciencedaily.com/releases/1999/02/990212101121.htm>.
University Of Michigan. (1999, February 16). H Pylori Screening May Reduce Gastric Cancer Risk. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/1999/02/990212101121.htm
University Of Michigan. "H Pylori Screening May Reduce Gastric Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/1999/02/990212101121.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins